title: Coagulopathy in a patient with nephrotic syndrome.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Shari
authors.initials: S
authors.lastname: Ghanny
authors.forename: Catherine
authors.initials: C
authors.lastname: Ross
authors.forename: Anthony K C
authors.initials: AK
authors.lastname: Chan
authors.forename: Howard H W
authors.initials: HH
authors.lastname: Chan
mesh_terms: D000682:Amyloid / Q000097:blood; D000686:Amyloidosis / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000378:metabolism; D003907:Dexamethasone / Q000008:administration & dosage; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D019934:International Normalized Ratio; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D010314:Partial Thromboplastin Time; D014812:Vitamin K / Q000008:administration & dosage
chemical_list: D000682:Amyloid; D000933:Antifibrinolytic Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D001779:Blood Coagulation Factors; D007145:Immunoglobulin kappa-Chains; D014812:Vitamin K; D003907:Dexamethasone; D008558:Melphalan